Global Drugs for Osteoarthritis Pain Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Drugs for Osteoarthritis Pain
    1.2 Classification of Drugs for Osteoarthritis Pain by Type
        1.2.1 Overview: Global Drugs for Osteoarthritis Pain Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Type in 2021
        1.2.3 Oral
        1.2.4 Injection
        1.2.5 External
    1.3 Global Drugs for Osteoarthritis Pain Market by Application
        1.3.1 Overview: Global Drugs for Osteoarthritis Pain Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Medical Care
        1.3.3 Personal Care
    1.4 Global Drugs for Osteoarthritis Pain Market Size & Forecast
    1.5 Global Drugs for Osteoarthritis Pain Market Size and Forecast by Region
        1.5.1 Global Drugs for Osteoarthritis Pain Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Drugs for Osteoarthritis Pain Market Size by Region, (2017-2022)
        1.5.3 North America Drugs for Osteoarthritis Pain Market Size and Prospect (2017-2028)
        1.5.4 Europe Drugs for Osteoarthritis Pain Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Drugs for Osteoarthritis Pain Market Size and Prospect (2017-2028)
        1.5.6 South America Drugs for Osteoarthritis Pain Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Drugs for Osteoarthritis Pain Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Drugs for Osteoarthritis Pain Market Drivers
        1.6.2 Drugs for Osteoarthritis Pain Market Restraints
        1.6.3 Drugs for Osteoarthritis Pain Trends Analysis
2 Company Profiles
    2.1 Pfizer
        2.1.1 Pfizer Details
        2.1.2 Pfizer Major Business
        2.1.3 Pfizer Drugs for Osteoarthritis Pain Product and Solutions
        2.1.4 Pfizer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Pfizer Recent Developments and Future Plans
    2.2 Johnson & Johnson
        2.2.1 Johnson & Johnson Details
        2.2.2 Johnson & Johnson Major Business
        2.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Product and Solutions
        2.2.4 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Johnson & Johnson Recent Developments and Future Plans
    2.3 GlaxoSmithKline
        2.3.1 GlaxoSmithKline Details
        2.3.2 GlaxoSmithKline Major Business
        2.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Product and Solutions
        2.3.4 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 GlaxoSmithKline Recent Developments and Future Plans
    2.4 Bayer
        2.4.1 Bayer Details
        2.4.2 Bayer Major Business
        2.4.3 Bayer Drugs for Osteoarthritis Pain Product and Solutions
        2.4.4 Bayer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Bayer Recent Developments and Future Plans
    2.5 Eli Lilly
        2.5.1 Eli Lilly Details
        2.5.2 Eli Lilly Major Business
        2.5.3 Eli Lilly Drugs for Osteoarthritis Pain Product and Solutions
        2.5.4 Eli Lilly Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Eli Lilly Recent Developments and Future Plans
    2.6 Novartis
        2.6.1 Novartis Details
        2.6.2 Novartis Major Business
        2.6.3 Novartis Drugs for Osteoarthritis Pain Product and Solutions
        2.6.4 Novartis Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Novartis Recent Developments and Future Plans
    2.7 Sanofi
        2.7.1 Sanofi Details
        2.7.2 Sanofi Major Business
        2.7.3 Sanofi Drugs for Osteoarthritis Pain Product and Solutions
        2.7.4 Sanofi Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Sanofi Recent Developments and Future Plans
    2.8 Horizon Pharma
        2.8.1 Horizon Pharma Details
        2.8.2 Horizon Pharma Major Business
        2.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Product and Solutions
        2.8.4 Horizon Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Horizon Pharma Recent Developments and Future Plans
    2.9 Abbott
        2.9.1 Abbott Details
        2.9.2 Abbott Major Business
        2.9.3 Abbott Drugs for Osteoarthritis Pain Product and Solutions
        2.9.4 Abbott Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Abbott Recent Developments and Future Plans
    2.10 Mylan 
        2.10.1 Mylan Details
        2.10.2 Mylan Major Business
        2.10.3 Mylan Drugs for Osteoarthritis Pain Product and Solutions
        2.10.4 Mylan Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Mylan Recent Developments and Future Plans
    2.11 Daiichi Sankyo
        2.11.1 Daiichi Sankyo Details
        2.11.2 Daiichi Sankyo Major Business
        2.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Product and Solutions
        2.11.4 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Daiichi Sankyo Recent Developments and Future Plans
    2.12 TEVA
        2.12.1 TEVA Details
        2.12.2 TEVA Major Business
        2.12.3 TEVA Drugs for Osteoarthritis Pain Product and Solutions
        2.12.4 TEVA Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 TEVA Recent Developments and Future Plans
    2.13 Almatica Pharma
        2.13.1 Almatica Pharma Details
        2.13.2 Almatica Pharma Major Business
        2.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Product and Solutions
        2.13.4 Almatica Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 Almatica Pharma Recent Developments and Future Plans
    2.14 Astellas Pharma
        2.14.1 Astellas Pharma Details
        2.14.2 Astellas Pharma Major Business
        2.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Product and Solutions
        2.14.4 Astellas Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.14.5 Astellas Pharma Recent Developments and Future Plans
    2.15 Tide Pharmaceutical
        2.15.1 Tide Pharmaceutical Details
        2.15.2 Tide Pharmaceutical Major Business
        2.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Product and Solutions
        2.15.4 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.15.5 Tide Pharmaceutical Recent Developments and Future Plans
    2.16 Iroko Pharmaceuticals
        2.16.1 Iroko Pharmaceuticals Details
        2.16.2 Iroko Pharmaceuticals Major Business
        2.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product and Solutions
        2.16.4 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.16.5 Iroko Pharmaceuticals Recent Developments and Future Plans
    2.17 Hengrui Pharmaceutical
        2.17.1 Hengrui Pharmaceutical Details
        2.17.2 Hengrui Pharmaceutical Major Business
        2.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product and Solutions
        2.17.4 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.17.5 Hengrui Pharmaceutical Recent Developments and Future Plans
    2.18 Abiogen Pharma
        2.18.1 Abiogen Pharma Details
        2.18.2 Abiogen Pharma Major Business
        2.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Product and Solutions
        2.18.4 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.18.5 Abiogen Pharma Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Drugs for Osteoarthritis Pain Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Drugs for Osteoarthritis Pain Players Market Share in 2021
        3.2.2 Top 10 Drugs for Osteoarthritis Pain Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Drugs for Osteoarthritis Pain Players Head Office, Products and Services Provided
    3.4 Drugs for Osteoarthritis Pain Mergers & Acquisitions
    3.5 Drugs for Osteoarthritis Pain New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Drugs for Osteoarthritis Pain Revenue and Market Share by Type (2017-2022)
    4.2 Global Drugs for Osteoarthritis Pain Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2017-2022)
    5.2 Global Drugs for Osteoarthritis Pain Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
    6.1 North America Drugs for Osteoarthritis Pain Revenue by Type (2017-2028)
    6.2 North America Drugs for Osteoarthritis Pain Revenue by Application (2017-2028)
    6.3 North America Drugs for Osteoarthritis Pain Market Size by Country
        6.3.1 North America Drugs for Osteoarthritis Pain Revenue by Country (2017-2028)
        6.3.2 United States Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)
        6.3.3 Canada Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)
        6.3.4 Mexico Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
    7.1 Europe Drugs for Osteoarthritis Pain Revenue by Type (2017-2028)
    7.2 Europe Drugs for Osteoarthritis Pain Revenue by Application (2017-2028)
    7.3 Europe Drugs for Osteoarthritis Pain Market Size by Country
        7.3.1 Europe Drugs for Osteoarthritis Pain Revenue by Country (2017-2028)
        7.3.2 Germany Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)
        7.3.3 France Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)
        7.3.5 Russia Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)
        7.3.6 Italy Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Type (2017-2028)
    8.2 Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Application (2017-2028)
    8.3 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Region
        8.3.1 Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Region (2017-2028)
        8.3.2 China Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)
        8.3.3 Japan Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)
        8.3.4 South Korea Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)
        8.3.5 India Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)
        8.3.7 Australia Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
    9.1 South America Drugs for Osteoarthritis Pain Revenue by Type (2017-2028)
    9.2 South America Drugs for Osteoarthritis Pain Revenue by Application (2017-2028)
    9.3 South America Drugs for Osteoarthritis Pain Market Size by Country
        9.3.1 South America Drugs for Osteoarthritis Pain Revenue by Country (2017-2028)
        9.3.2 Brazil Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)
        9.3.3 Argentina Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Drugs for Osteoarthritis Pain Revenue by Type (2017-2028)
    10.2 Middle East & Africa Drugs for Osteoarthritis Pain Revenue by Application (2017-2028)
    10.3 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country
        10.3.1 Middle East & Africa Drugs for Osteoarthritis Pain Revenue by Country (2017-2028)
        10.3.2 Turkey Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)
        10.3.4 UAE Drugs for Osteoarthritis Pain Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer